Raymond James & Associates’s Enviva Inc. EVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$6.81K Buy
16,823
+757
+5% +$330 ﹤0.01% 3978
2024
Q2
$6.91K Buy
16,066
+150
+0.9% +$75 ﹤0.01% 3937
2024
Q1
$7K Sell
15,916
-3,525
-18% -$1.85K ﹤0.01% 3906
2023
Q4
$19.4K Sell
19,441
-19,142
-50% -$53.1K ﹤0.01% 3771
2023
Q3
$288K Sell
38,583
-20,112
-34% -$209K ﹤0.01% 3248
2023
Q2
$637K Sell
58,695
-24,848
-30% -$362K ﹤0.01% 2774
2023
Q1
$2.41M Sell
83,543
-154,574
-65% -$6.31M ﹤0.01% 1920
2022
Q4
$12.6M Buy
238,117
+154,493
+185% +$8.83M 0.01% 877
2022
Q3
$5.02M Sell
83,624
-22,544
-21% -$1.52M 0.01% 1379
2022
Q2
$6.08M Sell
106,168
-7,515
-7% -$566K 0.01% 1269
2022
Q1
$9M Buy
113,683
+24,077
+27% +$1.76M 0.01% 1129
2021
Q4
$6.31M Sell
89,606
-3,674
-4% -$246K 0.01% 1395
2021
Q3
$5.05M Buy
93,280
+1,832
+2% +$98.5K ﹤0.01% 1488
2021
Q2
$4.79M Buy
91,448
+27,917
+44% +$1.38M ﹤0.01% 1521
2021
Q1
$3.07M Sell
63,531
-12,356
-16% -$611K ﹤0.01% 1747
2020
Q4
$3.45M Buy
75,887
+405
+0.5% +$17.7K ﹤0.01% 1553
2020
Q3
$3.04M Buy
75,482
+6,134
+9% +$241K ﹤0.01% 1499
2020
Q2
$2.5M Buy
69,348
+8,272
+14% +$275K ﹤0.01% 1591
2020
Q1
$1.63M Buy
61,076
+9,044
+17% +$315K ﹤0.01% 1692
2019
Q4
$1.94M Buy
52,032
+6,182
+13% +$210K ﹤0.01% 1842
2019
Q3
$1.47M Buy
45,850
+6,913
+18% +$213K ﹤0.01% 1948
2019
Q2
$1.22M Buy
38,937
+2,391
+7% +$75.8K ﹤0.01% 2099
2019
Q1
$1.18M Buy
36,546
+786
+2% +$23.5K ﹤0.01% 2103
2018
Q4
$992K Sell
35,760
-1,227
-3% -$36.3K ﹤0.01% 2098
2018
Q3
$1.18M Buy
36,987
+3,982
+12% +$122K ﹤0.01% 2142
2018
Q2
$960K Buy
33,005
+1,479
+5% +$42.8K ﹤0.01% 2245
2018
Q1
$864K Buy
31,526
+7,201
+30% +$197K ﹤0.01% 2238
2017
Q4
$673K Sell
24,325
-2,962
-11% -$85.2K ﹤0.01% 2367
2017
Q3
$806K Buy
27,287
+565
+2% +$16.3K ﹤0.01% 2225
2017
Q2
$735K Buy
26,722
+1,635
+7% +$45.9K ﹤0.01% 2209
2017
Q1
$705K Buy
25,087
+163
+0.7% +$4.51K ﹤0.01% 2185
2016
Q4
$668K Buy
24,924
+177
+0.7% +$4.81K ﹤0.01% 2157
2016
Q3
$668K Buy
24,747
+4,793
+24% +$116K ﹤0.01% 2098
2016
Q2
$454K Buy
19,954
+8,028
+67% +$179K ﹤0.01% 2159
2016
Q1
$259K Buy
+11,926
New +$225K ﹤0.01% 2428

Other funds holding EVA

Raymond James & Associates's EVA Position: Q3 2024 in Review

Raymond James & Associates increased its Enviva Inc. (EVA) stake by 4.7% in Q3 2024, buying an estimated $330 and bringing the position to 16,823 shares worth $6.81K. The position accounts for ﹤0.01% of the portfolio, ranked #3978.

Raymond James & Associates first reported a position in EVA in Q1 2016 and has held it in 35 quarters since. The position peaked at $12.6M in Q4 2022. 69 funds tracked by Wall St. Rank hold EVA as of Q3 2024.

  • Raymond James & Associates held 16,823 shares of Enviva Inc. worth $6.81K as of Q3 2024.
  • Raymond James & Associates bought 757 Enviva Inc. shares in Q3 2024, an estimated $330.
  • Enviva Inc. made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3978 holding.
  • Raymond James & Associates first reported a position in Enviva Inc. in Q1 2016 and has held it in 35 quarters since.
  • Raymond James & Associates's Enviva Inc. position peaked at $12.6M in Q4 2022.
  • 69 funds tracked by Wall St. Rank held Enviva Inc. as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.